Abstract
Ischemic stroke (IS) is a leading cause of death and disability worldwide, and angiogenesis is a critical target for its treatment. However, the regulatory mechanisms of competitive endogenous RNA (ceRNA) in IS-induced angiogenesis remain poorly understood. This study utilized a bioinformatics approach to explore these roles, identifying key mRNA modules and constructing a regulatory network. We identified four hub genes—NR4A1, PTGS2, EGR3, and VEGFA—and a central lncRNA, HCG18, which acts as a molecular sponge for miRNAs. The resulting HCG18-mediated ceRNA network likely regulates angiogenesis through the NF-kB-TNFA and hypoxia signaling pathways, providing potential new biomarkers and therapeutic targets for stroke recovery.
Introduction
Ischemic stroke (IS) remains a primary driver of global disability. While immediate clinical goals focus on restoring blood flow, long-term recovery depends on "neurorestoration," a process heavily reliant on angiogenesis—the growth of new blood vessels. These vessels are essential for delivering oxygen and nutrients to damaged brain tissue.
Recent research has highlighted the importance of competitive endogenous RNAs (ceRNAs). In this regulatory "shell game," long non-coding RNAs (lncRNAs) act as sponges to sequester microRNAs (miRNAs), thereby preventing them from silencing their target messenger RNAs (mRNAs). This study aims to map the specific ceRNA interactions that drive angiogenesis following a stroke to identify novel therapeutic avenues.
Methodology
The researchers employed a multi-omic bioinformatics pipeline, integrating data from three public Gene Expression Omnibus (GEO) datasets: GSE22255 (mRNA), GSE55937 (miRNA), and GSE102541 (lncRNA).
The study utilized Weighted Gene Co-expression Network Analysis (WGCNA) to identify functional gene clusters and the limma R package for differential expression analysis. Interaction data from the StarBase database was used to construct the ceRNA network, while Gene Set Enrichment Analysis (GSEA) characterized the biological pathways involved.
Results: The HCG18 Regulatory Axis
Out of 21 identified gene modules, the "cyan" module was most strongly associated with angiogenesis. Within this module, four hub genes—NR4A1, PTGS2, EGR3, and VEGFA—were identified as key drivers of vessel remodeling.
A central finding was the role of the lncRNA HCG18, which was significantly up-regulated in stroke patients. HCG18 was predicted to sequester two specific microRNAs: hsa-let-7i-5p and hsa-miR-148a-3p. By sponging these miRNAs, HCG18 protects the hub genes from degradation, allowing them to promote cell proliferation and repair.
The final ceRNA network highlights two specific interaction axes:
- HCG18 / hsa-let-7i-5p / NR4A1, PTGS2, EGR3
- HCG18 / hsa-miR-148a-3p / PTGS2, EGR3, VEGFA
GSEA suggested that this network operates primarily through the NF-κB-TNFA signaling pathway and the cellular response to hypoxia, both of which are classic triggers for post-stroke inflammation and repair.
Discussion and Future Directions
This study provides a comprehensive computational roadmap of the regulatory landscape of post-stroke angiogenesis. The identification of the HCG18-mediated axis offers specific targets for future therapies aimed at stimulating brain repair.
However, the authors acknowledge that this study is entirely bioinformatics-based. Future research must include "wet lab" validation—using cell cultures and animal models—to prove that manipulating HCG18 can functionally increase angiogenesis in a living brain. Furthermore, the small sample sizes in the lncRNA datasets suggest that these findings should be validated in larger clinical cohorts to ensure their translational potential.
Summary updated